title: Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension.
abstract: Pulmonary hypertension is a prevalent complication of chronic obstructive pulmonary disease (COPD) that is associated with poor prognosis. Although pulmonary hypertension is usually diagnosed in patients with advanced disease, changes in pulmonary vessels are already apparent at early disease stages, and in smokers without airflow obstruction. Changes in pulmonary vessels include intimal hyperplasia, resulting from proliferating mesenchymal cells, and elastic and collagen deposition as well as endothelial dysfunction. Dysregulation of endothelium-derived mediators and growth factors and inflammatory mechanisms underlie the endothelial dysfunction and vessel remodeling. Circumstantial and experimental evidence suggests that cigarette smoke products can initiate pulmonary vascular changes in COPD and that, at advanced disease stages, hypoxia may amplify the effects of cigarette smoke on pulmonary arteries. Bone marrow-derived progenitor cells may contribute to vessel repair and to vessel remodeling, a process that appears to be facilitated by transforming growth factor-β.
authors: Department of Pulmonary Medicine, Hospital Clinic, University of Barcelona; Biomedical Research Institute August Pi i Sunyer (IDIBAPS); Research Center Network for Respiratory Diseases (CIBERES); Barcelona, Spain.
authors: Joan Albert
authors: JA
authors: Barberà
keywords: cigarette smoke; endothelium; progenitor cells; vascular remodeling
references: Am J Respir Crit Care Med. 2003 May 1;167(9):1250-6
references: 12615615
references: Am J Respir Crit Care Med. 1999 Jan;159(1):158-64
references: 9872834
references: Cardiovasc Res. 2007 Dec 1;76(3):517-27
references: 17850777
references: Pulm Pharmacol Ther. 2011 Feb;24(1):32-41
references: 20970515
references: Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1605-11
references: 10228134
references: COPD. 2012 Aug;9(5):473-84
references: 22708688
references: Am J Respir Cell Mol Biol. 1998 Nov;19(5):819-25
references: 9806747
references: Am J Respir Crit Care Med. 2007 Apr 1;175(7):676-85
references: 17255567
references: Eur Heart J. 2009 Apr;30(8):890-9
references: 19299431
references: Chest. 2005 May;127(5):1531-6
references: 15888824
references: Chest. 1995 May;107(5):1193-8
references: 7750305
references: Arterioscler Thromb Vasc Biol. 1997 Apr;17(4):665-71
references: 9108778
references: Eur Respir J. 2011 Sep;38(3):617-27
references: 21310874
references: Am J Respir Cell Mol Biol. 2006 Mar;34(3):257-63
references: 16239642
references: Eur Respir J. 2006 Sep;28(3):556-62
references: 16737987
references: Am J Respir Crit Care Med. 2001 Aug 15;164(4):709-13
references: 11520741
references: Am J Physiol. 1998 Jun;274(6):L908-13
references: 9609729
references: Exp Lung Res. 1991 Nov-Dec;17(6):997-1009
references: 1769357
references: Lung. 1992;170(2):109-24
references: 1501507
references: Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66
references: 11994736
references: Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):423-9
references: 8306040
references: Eur Respir J. 2003 May;21(5):892-905
references: 12765440
references: Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L1-8
references: 17384082
references: Respir Res. 2009 Aug 14;10:76
references: 19682386
references: N Engl J Med. 1991 May 30;324(22):1539-47
references: 2027358
references: Eur Respir J. 2002 Apr;19(4):632-8
references: 11998991
references: Cell. 2011 Oct 14;147(2):293-305
references: 22000010
references: Chest. 2008 Oct;134(4):808-814
references: 18842913
references: Thorax. 1988 Mar;43(3):183-9
references: 3406902
references: Eur Respir J. 2002 Aug;20(2):332-8
references: 12212964
references: Chest. 1998 Sep;114(3 Suppl):213S-224S
references: 9741572
references: Am J Respir Crit Care Med. 1999 Aug;160(2):711-7
references: 10430750
references: Curr Opin Hematol. 2009 Jul;16(4):269-73
references: 19417649
references: Cardiovasc Res. 2010 Dec 1;88(3):502-11
references: 20631156